Results 211 to 220 of about 159,425 (263)

A White Paper on Advancing Long‐Acting Therapeutics for Maternal and Pediatric Health by Bridging Gaps in Clinical Research, Access and Regulation

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
As use cases for long‐acting therapeutics expand across clinical indications, there is a critical need to ensure the inclusion of women who are pregnant or breastfeeding, infants and children—populations with a historical gap in the availability of interventions already approved for use in adults.
Moherndran Archary   +59 more
wiley   +1 more source

Long‐Acting Therapeutics in Pediatric Health: Bridging Innovation and Access

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Children have distinct therapeutic needs arising from age‐dependent physiology, disease epidemiology, formulation requirements, dosing considerations, and safety vulnerabilities. Despite substantial reductions in childhood mortality over the past three decades, nearly 5 million children under five died in 2023, with infectious diseases continuing to ...
Prajith Venkatasubramanian   +5 more
wiley   +1 more source

Unmasking Malaria: Microscopy and nPCR Reveal the Hidden Misdiagnosis of Plasmodium Infections Among Febrile Pediatric in Northwest Ethiopia

open access: yesInterdisciplinary Perspectives on Infectious Diseases
Sisay Getie   +6 more
doaj   +1 more source

Phase I Evaluation of Siltartoxatug, a First‐in‐Class Anti‐Tetanus Monoclonal Antibody: Safety, Pharmacokinetics and Pharmacodynamics in Healthy Australian and Chinese Populations

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Siltartoxatug, a first‐in‐class monoclonal antibody targeting tetanus toxin for post‐exposure prophylaxis, was evaluated in two phase I trials in Australian and Chinese healthy adults. In these randomized, double‐blind, placebo‐controlled, dose‐escalation studies, participants received a single intramuscular injection of siltartoxatug (10–250 μg/kg) or
Xinyu Liu   +15 more
wiley   +1 more source

Diagnostic Lag in Precision Medicine

open access: yes
Clinical Pharmacology &Therapeutics, EarlyView.
Petr Heneberg
wiley   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Prophylaxis of Endocarditis

Acta Clinica Belgica, 1994
For a long time it has been known that bacteraemias caused by medical or dental procedures may cause endocarditis in patients with specific types of congenital or acquired heart disease. In the 1940s it was thought that the administration of antibiotics before such procedures would prevent endocarditis. However, the beneficial effect of this preventive
openaire   +5 more sources

Prophylaxis of Endophthalmitis

Ophthalmic Surgery, Lasers and Imaging Retina, 1994
ABSTRACT Prophylactic antibiotics can be administered by various routes to prevent endophthalmitis. Topical application is simple and minimally invasive, but it provides relatively poor penetration into the vitreous. Collagen shields are effective in delivering therapeutic levels of antibiotics to the cornea and aqueous but not to the ...
G A, Peyman, M, Daun
openaire   +2 more sources

Prophylaxis or No Prophylaxis before Transesophageal Echocardiography?

Journal of the American Society of Echocardiography, 1992
The rationale for prevention of endocarditis is obvious. Infective endocarditis is a serious disease that carries with it significant mortality and morbidity. Even though the etiologic organisms can be effectively treated with appropriate antimicrobial therapy, the disease often leaves behind an unwelcome legacy of valvular destruction, resulting in ...
openaire   +2 more sources

Prophylaxis in Diverticulitis

JAMA: The Journal of the American Medical Association, 1965
To the Editor:— As the number of aging persons in our population increases, diverticulosis and diverticulitis can be expected to become a more widespread medical problem. It is estimated that 5% to 10% of those over 40 have diverticulosis, and the percentage increases with age.
openaire   +2 more sources

Home - About - Disclaimer - Privacy